Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Mar 09, 2022 11:20am
154 Views
Post# 34499500

RE:RE:RE:RE:Expert techincal Analysis

RE:RE:RE:RE:Expert techincal Analysis
Domino55 wrote: I doubt that Joe 6 pack ever hears about Spectral.

BTW I was a bit misleading in the daily volume figure yesterday - if you actually go back to the "The trial is delivering better than expected results" disclosure, the AMERICAN FDA confirmatory P3 trial that is, dollar volume of EDTXF is closer to $63.00 daily.

Is 63 bucks daily enough to provide TA?

it would be half that or less without US IR in place now for over a year.




But Dom, you understand that is the intentional program being run right now, right?

Where's Walden has done an excellent job of  "turning up missing", so far.  There is some speculation amoungst a group of peers, that the SD event, just might be some sort of "coming out" party.  Fingers crossed.  But we have been wrong before.

Either way, the Tigris enrollment chart inexorably rises from left to right.  The ultimate exit /cash-out plan requires that it be so.

Bihl, Walker, Kellum, Ronco, Baxter, Infomed, Toray, Birch Hill, AGP, etc. are not, I suspect, in this for some laughs only.

MM
<< Previous
Bullboard Posts
Next >>